Diabetic retinopathy is a severe complication of diabetes that can lead to blindness. The Japanese clinical practice ...

As the world prepares for a “diabetes tsunami,” eye care experts believe AI could be key to saving health systems money.

Alvotech (ALVO) and Teva Pharmaceuticals (TEVA) announced that the FDA has accepted for review a Biologics License Application, or BLA, for ...

The Government of Kerala, in collaboration with Remidio, a leader in AI-driven ophthalmic screening solutions, has launched ...

Vision changes are an inevitable part of aging, but why are some more susceptible to age-related eye diseases and why do some ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic macular edema (DME) who have previously responded to at least 2 ...

In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

A retinal scan of a young mouse genetically predisposed to diabetes and obesity. Over time, the retina undergoes changes consistent with diabetic retinopathy, a condition where blood vessels swell or ...

Ocular biomarkers for anemia in diabetic kidney disease include disruption of the external limiting membrane and ellipsoid zone.

Dec. 12, 2024 — Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be directly attributed to hypertension or other cardiovascular ...

Intermittent fasting is an eating pattern that involves periods of voluntary fasting. Several methods exist, each with various time frames for fasting and eating. Intermittent fasting may benefit ...